Search research articles
Contact Us
Filters
Showing results (1061-1070 of 1,089) with videos related to
Page
of 109
Sort By:
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research
|
November 20, 2008
Denosumab, a fully human monoclonal antibody to RANKL, inhibits bone resorption and increases BMD in knock-in mice that express chimeric (murine/human) RANKL
Paul J Kostenuik, Hung Q Nguyen, James McCabe, et al.
Journal of the American Society of Nephrology : JASN
|
November 28, 2012
Inhibition of WISE preserves renal allograft function
Xueming Qian, Xiaodong Yuan, Steven Vonderfecht, et al.
Human Mutation
|
June 24, 2019
Identification of mobile retrocopies during genetic testing: Consequences for routine diagnosis
Nicolas Chatron, Kevin Cassinari, Olivier Quenez, et al.
European Journal of Cancer (Oxford, England : 1990)
|
February 21, 2022
Parallel evolution and differences in seroprevalence of SARS-CoV-2 antibody between patients with cancer and health care workers in a tertiary cancer centre during the first and second wave of COVID-19 pandemic: canSEROcov-II cross-sectional study
Sylvain Ladoire, Emilie Rederstorff, Vincent Goussot, et al.
Cancer Medicine
|
December 9, 2022
Retrospective, real-life study of venetoclax plus azacitidine or low-dose cytarabine in French patients with acute myeloid leukemia ineligible for intensive chemotherapy
Louise Laloi, Natacha Chaumard Billotey, Pierre-Yves Dumas, et al.
European Journal of Cancer (Oxford, England : 1990)
|
March 29, 2021
Seroprevalence of SARS-CoV-2 among the staff and patients of a French cancer centre after first lockdown: The canSEROcov study
Sylvain Ladoire, Vincent Goussot, Emilie Redersdorff, et al.
Circulation. Genomic and Precision Medicine
|
March 7, 2020
Genetic Association Analyses Highlight <i>IL6</i>, <i>ALPL</i>, and <i>NAV1</i> As 3 New Susceptibility Genes Underlying Calcific Aortic Valve Stenosis
Sébastien Thériault, Christian Dina, David Messika-Zeitoun, et al.
Standards in Genomic Sciences
|
August 21, 2013
Meeting report: 1st international functional metagenomics workshop may 7-8, 2012, st. Jacobs, ontario, Canada
Katja Engel, Deborah Ashby, Sean F Brady, et al.
Cell
|
April 18, 1997
Osteoprotegerin: a novel secreted protein involved in the regulation of bone density
W S Simonet, D L Lacey, C R Dunstan, et al.
The Lancet. Haematology
|
May 2, 2026
Final results of nilotinib versus nilotinib combined with pegylated interferon alfa-2a as first-line therapy in chronic phase chronic myeloid leukaemia in France (PETALs): an open-label, multicentre, randomised phase 3 trial
Franck E Nicolini, Gabriel Etienne, Françoise Huguet, et al.
Page
of 109
Search research articles
Search
Showing results (1061-1070 of 1,089) with videos related to
Sort By:
Page
of 109
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research
|
November 20, 2008
Denosumab, a fully human monoclonal antibody to RANKL, inhibits bone resorption and increases BMD in knock-in mice that express chimeric (murine/human) RANKL
Paul J Kostenuik, Hung Q Nguyen, James McCabe, et al.
Journal of the American Society of Nephrology : JASN
|
November 28, 2012
Inhibition of WISE preserves renal allograft function
Xueming Qian, Xiaodong Yuan, Steven Vonderfecht, et al.
Human Mutation
|
June 24, 2019
Identification of mobile retrocopies during genetic testing: Consequences for routine diagnosis
Nicolas Chatron, Kevin Cassinari, Olivier Quenez, et al.
European Journal of Cancer (Oxford, England : 1990)
|
February 21, 2022
Parallel evolution and differences in seroprevalence of SARS-CoV-2 antibody between patients with cancer and health care workers in a tertiary cancer centre during the first and second wave of COVID-19 pandemic: canSEROcov-II cross-sectional study
Sylvain Ladoire, Emilie Rederstorff, Vincent Goussot, et al.
Cancer Medicine
|
December 9, 2022
Retrospective, real-life study of venetoclax plus azacitidine or low-dose cytarabine in French patients with acute myeloid leukemia ineligible for intensive chemotherapy
Louise Laloi, Natacha Chaumard Billotey, Pierre-Yves Dumas, et al.
European Journal of Cancer (Oxford, England : 1990)
|
March 29, 2021
Seroprevalence of SARS-CoV-2 among the staff and patients of a French cancer centre after first lockdown: The canSEROcov study
Sylvain Ladoire, Vincent Goussot, Emilie Redersdorff, et al.
Circulation. Genomic and Precision Medicine
|
March 7, 2020
Genetic Association Analyses Highlight <i>IL6</i>, <i>ALPL</i>, and <i>NAV1</i> As 3 New Susceptibility Genes Underlying Calcific Aortic Valve Stenosis
Sébastien Thériault, Christian Dina, David Messika-Zeitoun, et al.
Standards in Genomic Sciences
|
August 21, 2013
Meeting report: 1st international functional metagenomics workshop may 7-8, 2012, st. Jacobs, ontario, Canada
Katja Engel, Deborah Ashby, Sean F Brady, et al.
Cell
|
April 18, 1997
Osteoprotegerin: a novel secreted protein involved in the regulation of bone density
W S Simonet, D L Lacey, C R Dunstan, et al.
The Lancet. Haematology
|
May 2, 2026
Final results of nilotinib versus nilotinib combined with pegylated interferon alfa-2a as first-line therapy in chronic phase chronic myeloid leukaemia in France (PETALs): an open-label, multicentre, randomised phase 3 trial
Franck E Nicolini, Gabriel Etienne, Françoise Huguet, et al.
Page
of 109